NO831807L - Fremgangsmaater for fremstilling av terapeutisk aktive dihydropyridiner og mellomprodukter av fremgangsmaatene - Google Patents

Fremgangsmaater for fremstilling av terapeutisk aktive dihydropyridiner og mellomprodukter av fremgangsmaatene

Info

Publication number
NO831807L
NO831807L NO831807A NO831807A NO831807L NO 831807 L NO831807 L NO 831807L NO 831807 A NO831807 A NO 831807A NO 831807 A NO831807 A NO 831807A NO 831807 L NO831807 L NO 831807L
Authority
NO
Norway
Prior art keywords
procedures
intermediates
preparation
therapeutic active
dihydropyridines
Prior art date
Application number
NO831807A
Other languages
English (en)
Other versions
NO162515C (no
NO162515B (no
Inventor
Peder Bernhard Berntsson
Stig Aake Ingemar Carlsson
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NO831807L publication Critical patent/NO831807L/no
Publication of NO162515B publication Critical patent/NO162515B/no
Publication of NO162515C publication Critical patent/NO162515C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
NO831807A 1982-05-21 1983-05-20 Mellomprodukter. NO162515C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8203177 1982-05-21

Publications (3)

Publication Number Publication Date
NO831807L true NO831807L (no) 1983-11-22
NO162515B NO162515B (no) 1989-10-02
NO162515C NO162515C (no) 1990-01-10

Family

ID=20346868

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831807A NO162515C (no) 1982-05-21 1983-05-20 Mellomprodukter.

Country Status (19)

Country Link
EP (1) EP0095450A3 (no)
JP (1) JPS58210064A (no)
KR (1) KR900006116B1 (no)
AU (1) AU1464483A (no)
CA (1) CA1242201A (no)
DD (2) DD211554A5 (no)
DK (1) DK223783A (no)
ES (4) ES522573A0 (no)
FI (1) FI79300C (no)
GB (1) GB2120251B (no)
GR (1) GR78849B (no)
HU (2) HU188343B (no)
IL (1) IL68604A0 (no)
IS (1) IS1380B6 (no)
MW (1) MW2083A1 (no)
NO (1) NO162515C (no)
NZ (1) NZ204284A (no)
PT (1) PT76734B (no)
ZA (1) ZA833264B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204421B (it) * 1986-06-27 1989-03-01 Boehringer Biochemia Srl 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono
WO1987000836A1 (en) * 1985-08-06 1987-02-12 Boehringer Biochemia Robin S.P.A. Pharmaceutically active 2-thiomethyl-substituted-1,4-dihydropyridines
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
IT1213440B (it) * 1986-12-24 1989-12-20 Boehringer Biochemia Srl 2-ditioalchil-diidropiridine, un metodo per la loro preparazione e composizioni farmaceutiche chele contengono.
IT1204948B (it) * 1987-03-13 1989-03-10 Boheringer Biochemia Robin S P 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono.
DE3741540A1 (de) * 1987-12-08 1989-06-22 Bayer Ag Verfahren zur herstellung von unsymmetrischen dihydropyridinen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2740080A1 (de) * 1977-09-06 1979-03-15 Bayer Ag 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
GB2050375B (en) * 1979-05-11 1983-02-23 Fujisawa Pharmaceutical Co 4-cyanophenyl-1,4-dihydropyridine compound processes for preparation thereof and pharmaceutical composition comprising the same
SE7910521L (sv) * 1979-12-20 1981-06-21 Haessle Ab Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma

Also Published As

Publication number Publication date
ES542187A0 (es) 1985-12-16
EP0095450A2 (en) 1983-11-30
GB2120251B (en) 1985-11-27
IS1380B6 (is) 1989-08-28
EP0095450A3 (en) 1984-09-05
KR900006116B1 (ko) 1990-08-22
FI831779A0 (fi) 1983-05-19
ES8600242A1 (es) 1985-10-01
ES8603417A1 (es) 1985-12-16
GB2120251A (en) 1983-11-30
ES542185A0 (es) 1985-12-16
JPS58210064A (ja) 1983-12-07
AU1464483A (en) 1983-11-24
ES8603415A1 (es) 1985-12-16
NO162515C (no) 1990-01-10
DK223783D0 (da) 1983-05-19
FI831779L (fi) 1983-11-22
DK223783A (da) 1983-11-22
GB8314021D0 (en) 1983-06-29
NO162515B (no) 1989-10-02
PT76734B (en) 1986-03-27
MW2083A1 (en) 1985-06-12
ES522573A0 (es) 1985-10-01
KR840004724A (ko) 1984-10-24
CA1242201A (en) 1988-09-20
DD216454A5 (de) 1984-12-12
NZ204284A (en) 1985-11-08
GR78849B (no) 1984-10-02
ZA833264B (en) 1984-06-27
HU188343B (en) 1986-04-28
PT76734A (en) 1983-06-01
ES8603416A1 (es) 1985-12-16
DD211554A5 (de) 1984-07-18
ES542186A0 (es) 1985-12-16
HU193785B (en) 1987-11-30
FI79300B (fi) 1989-08-31
IL68604A0 (en) 1983-09-30
FI79300C (fi) 1989-12-11
IS2808A7 (is) 1983-11-22

Similar Documents

Publication Publication Date Title
NO841568L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater
IT1177553B (it) Composti farmacologicamente attivi per il trattamento di affezioni gastrointestinali e procedimento di preparazione
NO171209C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfinanestere
NO171638C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater
NO171269C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO834089L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina og palladium
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO841542L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater
NO844243L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme forbindelser
NO854369L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater
NO843042L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kumarin-derivater
NO830238L (no) Fremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer
NO172051C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreesterderivater og deglukoteicoplanin
NO168644C (no) Fremgangsmaate for fremstilling av terapeutisk aktive n-(pyrrol-1-yl)pyridinaminer
NO169067C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO831807L (no) Fremgangsmaater for fremstilling av terapeutisk aktive dihydropyridiner og mellomprodukter av fremgangsmaatene
NO843377L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater
NO820112L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
NO813263L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater
NO834437L (no) Fremgangsmaate for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater
NO170012C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider
NO831995L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2-metoksyetyl)-noroksymorfon
NO832430L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyleddiksyre-derivater